BC
IRWD icon

Brookfield Corp’s Ironwood Pharmaceuticals IRWD Stock Holding History

Brookfield Corp’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-153,198
Closed -$1.93M – 672
2022
Q1 		$1.93M Buy
+153,198
New +$1.76M 0.01% 408

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Brookfield Corp's IRWD Position: Q2 2022 in Review

Brookfield Corp sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 153,198 shares — an estimated $1.93M sold.

Brookfield Corp first reported a position in IRWD in Q1 2022 and held it in 1 quarter. The position peaked at $1.93M in Q1 2022. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • Brookfield Corp reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Brookfield Corp sold 153,198 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $1.93M.
  • Brookfield Corp first reported a position in Ironwood Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Brookfield Corp's Ironwood Pharmaceuticals position peaked at $1.93M in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Brookfield Corp's 13F filing for Q2 2022, filed 15 Aug 2022.